Fatigue Prevention and Management in Mine Workers

niversidade Federal de Ouro Preto0 个研究点开始时间: 2019年11月6日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Workers shortlisted for the high performance operator program according to the company's operational technical criteria will be included in the study

•Operators who submit will be excluded:
•Evidence of substance abuse or dependence in the last 5 years.
•Non-medical psychiatric treatment at least 4 weeks before study.
•Clinically significant 24-hour Holter abnormality as complex ventricular arrhythmias, defined as sustained ventricular tachycardia, second-degree mobitz type II or more atrioventricular block, sinus pauses longer than 3 seconds, presence of more than 30 episodes of extrasystoles per hour, and atrial fibrillation or flutter
•Decompensated metabolic disorders such as diabetes with glycated hemoglobin (HbA1c) greater than 9% and dyslipidemia with LDL greater than 180 mg / dL or triglycerides greater than 500 mg / dL.
•Degenerative chronic diseases (autoimmune, neoplasia, immunodeficient disease and neurological diseases).
•Operators with signs and symptoms of infectious diseases.
•Gastrointestinal disorders with altered absorption.
•Carriers of moderate to severe sleep disorder
•Using the following medicines: amitriptyline, clomipramine, imipramine, nortriptyline, fluoxetine, sertraline, paroxetine, venlafaxine, citalopram, lithium carbonate, valproic acid, sodium divalproate, carbamazepine, risperidone, olanzapine, haloperidol, monoaminoxpride inhibitors, moclobemide or selegiline.

发起方

niversidade Federal de Ouro Preto